Status | Study |
Completed |
Study Name: Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients Condition: Secondary Hyperparathyroidism Date: 2015-01-11 Interventions: Drug: Combination Cinacalcet with Vitamin D analogue Depending on the iPTH level and the serum calcium l |
Recruiting |
Study Name: The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis Condition: Secondary Hyperparathyroidism Maintenance Hemodialysis Date: 2015-01-04 Interventions: Procedure: microwave ablation |
Recruiting |
Study Name: Optimal Anemia Treatment in End Stage Renal Disease (ERSD) Condition: Hyperparathyroidism, Secondary Date: 2014-06-27 Interventions: Drug: standard care Standard c |
Completed |
Study Name: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis Condition: Secondary Hyperparathyroidism Date: 2014-05-14 Interventions: Drug: KHK7580 Oral administration |
Completed |
Study Name: A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis Condition: Secondary Hyperparathyroidism Date: 2014-04-29 Interventions: Drug: ASP7991 oral |
Terminated |
Study Name: Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis Condition: Chronic Kidney Disease, Secondary Hyperparathyroidism Date: 2014-04-01 Interventions: Drug: Cinacalcet HCl Capsules |
Active, not recruiting |
Study Name: To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis Condition: Hyperparathyroidism, Secondary Date: 2014-03-03 Interventions: Drug: AMG 416 Subjects will be administered IV AMG 416 at the end of their regular dialysis sessions on |
Completed |
Study Name: Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide Condition: Hyperparathyroidism, Secondary Date: 2013-08-28 Interventions: Drug: Etelcalcetide Etelcalcetide is provided as a sterile lyophilized powder to be reconstituted with s |
Completed |
Study Name: Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. Condition: Secondary Hyperparathyroidism Due to Renal Causes Date: 2013-08-28 Interventions: Drug: Paricalcitol 1 capsule/d |
Completed |
Study Name: A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis Condition: Hyperparathyroidism, Secondary Kidney Failure, Chronic Date: 2013-08-12 Interventions: Drug: DP001 softgel capsules Other Names: 2-methylene-19-nor-20S-1α |